![Nathan Hardy](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Profile
Presently, Nathan Hardy holds the position of Chief Financial Officer & Senior Vice President at Sana Biotechnology, Inc. In his past career Mr. Hardy was Executive Director & Head-Corporate Finance at Amgen, Inc. and Vice President-Finance for Juno Therapeutics, Inc. Mr. Hardy received an undergraduate degree from the University of Utah and an MBA from the University of Notre Dame.
Former positions of Nathan Hardy
| Companies | Position | End |
|---|---|---|
| SANA BIOTECHNOLOGY, INC. | Director of Finance/CFO | 04/10/2024 |
| JUNO THERAPEUTICS INC | Director of Finance/CFO | 01/06/2018 |
| AMGEN INC. | Director/Board Member | 01/08/2017 |
Training of Nathan Hardy
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
75
1st degree connections
5
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 5 |
|---|---|
Amgen, Inc.
 Amgen, Inc. BiotechnologyHealth Technology Discovers, develops, manufactures and delivers human therapeutics | Health Technology |
University of Notre Dame
 University of Notre Dame Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
University of Utah
 University of Utah Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Juno Therapeutics, Inc.
 Juno Therapeutics, Inc. BiotechnologyHealth Technology Operates as a biopharmaceutical company to treat cancer, HIV and cardiovascular diseases | Health Technology |
Sana Biotechnology, Inc.
 Sana Biotechnology, Inc. BiotechnologyHealth Technology Operates as a biotechnological company which creates and delivers engineered cells as medicine for patients | Health Technology |
- Stock Market
- Insiders
- Nathan Hardy
